Sign In
Buy CLRB
$2.60
-0.140 (-5.11%)
At Close: Jun 03, 2026
PDC Energy Launches $150 Million Tack-on Senior Notes Offering
11:35am, Thursday, 10'th Sep 2020
DENVER, Sep 10, 2020 (GLOBE NEWSWIRE via COMTEX) --
DENVER, Sept. 10, 2020 (GLOBE NEWSWIRE) -- PDC Energy, Inc. ("PDC" or the "Company") (Nasdaq:PDCE) today...
Synovus Financial Corp Sells 1,626 Shares of PDC Energy Inc (NASDAQ:PDCE)
07:32am, Friday, 28'th Aug 2020
Synovus Financial Corp cut its holdings in PDC Energy Inc (NASDAQ:PDCE) by 17.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commissi
Cellectar Presents Poster at the AACR VIRTUAL MEETING: ADVANCES IN MALIGNANT LYMPHOMA
02:01pm, Monday, 17'th Aug 2020
Poster highlights the Phase 2a study data in relapsed or refractory lymphoplasmacytic lymphoma (LPL)/Waldenstrom’s macroglobulinemia (WM) Interim results show 100% overall response rate and a 75% m
Cellectar Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
12:00pm, Monday, 10'th Aug 2020
FLORHAM PARK, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercializatio
Cellectar Announces Poster Presentation at the International Symposium on Pediatric Neuro-Oncology (ISPNO) Annual Meeting
12:00pm, Tuesday, 04'th Aug 2020
Data highlight results from the Phase 1 study of CLR 131 in children and adolescents with relapsed/refractory malignanciesFLORHAM PARK, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, I
Contango Oil & Gas: Back To Basics (NYSEMKT:MCF)
08:35pm, Monday, 03'rd Aug 2020
Insiders own nearly one-third of the common. The partnership with Brad Juneau is likely to be a core growth area in the future as it was in the past.
Lowest Insider Activity Since January - The Most Important Insider News (July 2020 Update)
05:51pm, Monday, 03'rd Aug 2020
Insider activity is very informative to follow as insiders know their company better than anyone else.
2 “Strong Buy” Healthcare Stocks That Could Be the Next M&A Target
07:31pm, Wednesday, 29'th Jul 2020
Which stocks have been the stars of 2020? Biotechs. Amid the onset of the global health crisis, companies advancing COVID-19 vaccines, treatments and testing kits have seen their shares take off rapid
Center for Learning in Retirement Hosts Fall Online Program
03:50pm, Wednesday, 22'nd Jul 2020
Check out the latest community post from one of your neighbors. (The views expressed in this post are the author’s own.)
Next Generation Pool Betting for Sports and Esports Fans Delivered by Low6 Sport Buff Partnership
12:00am, Wednesday, 22'nd Jul 2020
Low6, the sports betting leader in pool play and wagering, and Sport Buff, the company bringing next generation fan engagement and gamification to spo
Center for Learning in Retirement Hosts Fall Online Program
08:34pm, Tuesday, 21'st Jul 2020
Check out the latest community post from one of your neighbors. (The views expressed in this post are the author’s own.)
Center for Learning in Retirement Hosts Fall Online Program
08:29pm, Tuesday, 21'st Jul 2020
Check out the latest community post from one of your neighbors. (The views expressed in this post are the author’s own.)
Cellectar Announces Poster Presentation of Clinical Data at the American Association of Cancer Research (AACR) Annual Meeting
12:00pm, Tuesday, 21'st Jul 2020
FLORHAM PARK, N.J., July 21, 2020 -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and.
Akari Therapeutics (NASDAQ:AKTX) vs. Cellectar Biosciences (NASDAQ:CLRB) Head-To-Head Survey
01:54am, Sunday, 19'th Jul 2020
Cellectar Biosciences (NASDAQ:CLRB) and Akari Therapeutics (NASDAQ:AKTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength
